News

Immunotherapy before surgery killed off liver tumors in one-third of patients, study finds

FOX News

New York, NY
(January 27, 2022)

Thomas Marron, MD, PhD, discusses his research in a role for neoadjuvant immunotherapy in liver cancer.

Tags: Icahn School of Medicine at Mount Sinai, Liver Cancers, The Tisch Cancer Institute, Thomas Marron, MD, PhD

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

liver cancer

Press Release

Study Reveals a Trio of Immune Cells Vital in Response to Liver Cancer Immunotherapy

Jun 15, 2023 View All Press Releases

Press Release

Libtayo effective in killing HCC tumors prior to resection

Jan 19, 2022 View All Press Releases

New York skyscrapers

Press Release

Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells

Jan 19, 2022 View All Press Releases